Nkarta (NKTX) Non-Current Assets (2019 - 2026)

Nkarta's (NKTX) quarterly Non-Current Assets came in at $136.2 million in Q1 2026, down 31.58% year-on-year from $199.1 million in Q1 2025, and up 11.91% quarter-over-quarter from $121.7 million in Q4 2025.

Nkarta (NKTX) Non-Current Assets (2019 - 2026) Analysis & Trends

Nkarta's Non-Current Assets history runs 8 years deep, the most recent figure standing at $136.2 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 31.58% year-over-year to $136.2 million in Q1 2026; TTM through Mar 2026 was $547.6 million, a 38.55% decrease from a year earlier, with the FY2025 full-year figure at $121.7 million, down 46.59% from the prior year.
  • Non-Current Assets improved to $136.2 million in Q1 2026 per NKTX's latest filing, from $121.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $241.9 million in Q3 2024 and bottomed at $83.1 million in Q1 2022.
  • The 5-year median for Non-Current Assets is $134.2 million (2024), against an average of $145.7 million.
  • Across the five-year window, Non-Current Assets surged 299.14% in 2022 and slumped 46.59% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $112.2 million in 2022, then climbed by 12.08% to $125.8 million in 2023, then surged by 81.11% to $227.9 million in 2024, then tumbled by 46.59% to $121.7 million in 2025, then advanced by 11.91% to $136.2 million in 2026.
  • Per Business Quant, the three latest NKTX Non-Current Assets figures stand at $136.2 million (Q1 2026), $121.7 million (Q4 2025), and $138.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Nkarta 170.79 Mn 170.79 Mn - 136.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 136.19 Mn
Dec 31, 2025 121.70 Mn
Sep 30, 2025 137.96 Mn
Jun 30, 2025 151.74 Mn
Mar 31, 2025 199.06 Mn
Dec 31, 2024 227.87 Mn
Sep 30, 2024 241.88 Mn
Jun 30, 2024 222.29 Mn
Mar 31, 2024 134.16 Mn
Dec 31, 2023 125.81 Mn
Sep 30, 2023 124.68 Mn
Jun 30, 2023 142.30 Mn
Mar 31, 2023 125.98 Mn
Dec 31, 2022 112.25 Mn
Sep 30, 2022 102.88 Mn
Jun 30, 2022 86.26 Mn
Mar 31, 2022 83.08 Mn
Dec 31, 2021 28.12 Mn
Sep 30, 2021 27.83 Mn
Jun 30, 2021 25.18 Mn